Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma (Q40622986)
Jump to navigation
Jump to search
scientific article published on April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma |
scientific article published on April 2000 |
Statements
1 reference
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma (English)
1 reference
de Gast GC
1 reference
Klümpen HJ
1 reference
Vyth-Dreese FA
1 reference
Kersten MJ
1 reference
Verra NC
1 reference
Sein J
1 reference
Batchelor D
1 reference
Nooijen WJ
1 reference
Schornagel JH
1 reference
1 April 2000
1 reference
1 reference
6
1 reference
4
1 reference
1267-1272
1 reference
Identifiers
1 reference